Search

Search Results

• 

  Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity

  Y. Emad, T. Gheita, H. Darweesh, P. Klooster, R. Gamal, H. Fathi, N. El-Shaarawy, M. Gamil, M. Hawass, R.M. El-Refai, H. Al-Hanafi, S. Abd-Ellatif, A. Ismail, J. Rasker

  06-07-2018 Pages 85-91

  DOI https://doi.org/10.4081/reumatismo.2018.1027

  • 3,269 abstract views
  • 1,824 PDF
• 

  Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio

  E. Cipriano, F. Ceccarelli, L. Massaro, F. R. Spinelli, C. Alessandri, C. Perricone, G. Valesini, F. Conti

  16-09-2015 Pages 62-67

  DOI https://doi.org/10.4081/reumatismo.2015.828

  • 3,307 abstract views
  • 1,417 PDF
• 

  Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

  L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria

  11-12-2012 Pages 314-320

  DOI https://doi.org/10.4081/reumatismo.2012.314

  • 2,960 abstract views
  • 1,497 PDF
• 

  Typing TREX1 gene in patients with systemic lupus erythematosus

  M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani

  30-06-2015 Pages 1-7

  DOI https://doi.org/10.4081/reumatismo.2015.782

  • 3,842 abstract views
  • 2,040 PDF
• 

  Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case

  D. Jain, H.K. Aggarwal, V. Kaverappa, S. Dhayia, P. Jain, S. Yadav

  17-03-2014 Pages 302-306

  DOI https://doi.org/10.4081/reumatismo.2013.706

  • 5,770 abstract views
  • 1,572 PDF
• 

  Urinary CXCL10: a marker of nephritis in lupus patients

  M. A. Marie, R. E. Abu Khalil, H. M. Habib

  17-03-2014 Pages 292-297

  DOI https://doi.org/10.4081/reumatismo.2013.719

  • 3,510 abstract views
  • 1,978 PDF
• 

  Short story of antirheumatic therapy.VIII. The immunodepressants

  G. Pasero, P. Marson

  19-03-2012 Pages 44-54

  DOI https://doi.org/10.4081/reumatismo.2012.44

  • 1,906 abstract views
  • 1,667 PDF
• 

  Systemic lupus erythematosus presenting as fulminant lupus pneumonitis: a rare case report

  H.K. Aggarwal, D. Jain, A. Mittal, A. Rao, R.K. Yadav, P. Jain

  23-06-2016 Pages 48-52

  DOI https://doi.org/10.4081/reumatismo.2016.846

  • 3,525 abstract views
  • 1,970 PDF
• 

  Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

  M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini

  11-12-2012 Pages 321-325

  DOI https://doi.org/10.4081/reumatismo.2012.321

  • 2,538 abstract views
  • 1,477 PDF
• 

  Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

  A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

  20-12-2012 Pages 350-359

  DOI https://doi.org/10.4081/reumatismo.2012.350

  • 3,642 abstract views
  • 2,940 PDF
• 

  The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

  M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

  16-12-2016 Pages 137-143

  DOI https://doi.org/10.4081/reumatismo.2016.891

  • 2,867 abstract views
  • 1,567 PDF
• 

  Pain and systemic lupus erythematosus

  M. Di Franco, M.P. Guzzo, F.R. Spinelli, F. Atzeni, P. Sarzi-Puttini, F. Conti, C. Iannuccelli

  06-06-2014 Pages 33-38

  DOI https://doi.org/10.4081/reumatismo.2014.762

  • 6,210 abstract views
  • 3,155 PDF
• 

  Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

  F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò

  06-07-2018 Pages 100-105

  DOI https://doi.org/10.4081/reumatismo.2018.1023

  • 3,118 abstract views
  • 1,671 PDF
• 

  Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

  E. Chessa, M. Piga, A. Floris, A. Mathieu, A. Cauli

  21-12-2017 Pages 175-183

  DOI https://doi.org/10.4081/reumatismo.2017.1007

  • 4,715 abstract views
  • 2,107 PDF
• 

  Systemic vasculitis in a patient with rhupus syndrome

  O. Zengin, M. E. Onder, M. A. Sarica, I. H. Turkbeyler, G. Kimyon, Z. H. Demir, H. Yildiz, B. Kisacik, A. M. Onat

  23-05-2016 Pages 161-164

  DOI https://doi.org/10.4081/reumatismo.2015.858

  • 2,506 abstract views
  • 1,287 PDF
• 

  Spontaneous soft tissue haemorrhage in systemic lupus erythematosus

  M.C. Abdulla

  31-12-2016 Pages 199-202

  DOI https://doi.org/10.4081/reumatismo.2016.952

  • 2,339 abstract views
  • 1,115 PDF
• 

  Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study

  A.B. Rasheed, M.S. Daoud, F.I. Gorial

  21-12-2017 Pages 170-174

  DOI https://doi.org/10.4081/reumatismo.2017.998

  • 2,473 abstract views
  • 1,000 PDF
• 

  Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant

  N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria

  20-12-2012 Pages 380-387

  DOI https://doi.org/10.4081/reumatismo.2012.380

  • 2,922 abstract views
  • 1,133 PDF
• 

  Osteoporosis and rheumatic diseases

  N. Maruotti, A. Corrado, F.P. Cantatore

  28-06-2014 Pages 125-135

  DOI https://doi.org/10.4081/reumatismo.2014.785

  • 9,488 abstract views
  • 3,899 PDF

• PO:16:238 | Cardiovascular risk in systemic lupus erythematosus patients: comparison among Framingham Score, QRISK3, and SLECRE

  Francesca Vignoni^1|2, Serena Iodice², Cesare Tomasi², Chiara Orlandi^1|2, Eleonora Pedretti¹, Micaela Fredi², Franco Franceschini^1|2, Ilaria Cavazzana^1|2. | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2045

  • 296 abstract views
• 

  Temporomandibular joint dysfunction in various rheumatic diseases

  F.J. Aceves-Avila, M. Chávez-López, J.R. Chavira-González, C. Ramos-Remus

  24-07-2013 Pages 126-130

  DOI https://doi.org/10.4081/reumatismo.2013.126

  • 4,659 abstract views
  • 1,744 PDF
• 

  The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity

  W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi

  20-12-2018 Pages 241-250

  DOI https://doi.org/10.4081/reumatismo.2018.1075

  • 2,142 abstract views
  • 1,329 PDF

• PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement

  Fabio Brandolino¹, Giulia Pazzola¹, Luca Ronzoni³, Andreina Teresa Manfredi^1|2, Carlo Salvarani^1|2 | ¹SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; ²Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; ³SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2146

  • 467 abstract views
• 

  A rare form of anemia in systemic lupus erythematosus

  C.A. Mansoor, R. Narayan

  21-09-2017 Pages 119-121

  DOI https://doi.org/10.4081/reumatismo.2017.982

  • 3,581 abstract views
  • 1,303 PDF

• PO:16:232 | Belimumab step-down dose spacing in patients with systemic lupus erythematosus in persistent clinical remission: experience from a multicentric cohort

  Alice Bartoletti¹, Laura Giudice¹, Lorenza Maria Argolini^1|2, Giuseppe Alvise Ramirez³, Luca Moroni³, Tommaso Schioppo⁴, Chiara Bellocchi^5|6, Annalaura Fasiello⁶, Lorenzo Beretta⁶, Lorenzo Dagna³, Roberto Caporali¹, Maria Gerosa¹. | ¹UO Clinica Reumatologica, ASST Gaetano Pini CTO, Milano, Italy; ²UOC Medicina fisica e riabilitazione specialistica, ASST Gaetano Pini CTO, Milano, Italy; ³Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffa Milano Italy; ⁴Medicina Generale II, Servizio di Reumatologia, Ospedale San Paolo, ASST Santi Paolo Carlo, Milano, Italy; ⁵Department of Clinical Sciences and Community Health, University of Milan, Dipartimeto di Eccellenza 2023-2027, Milano, Italy; ⁶Referral Centre for Systemic Autoimmune DIseases, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2044

  • 436 abstract views
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  Pages 91-96

  DOI https://doi.org/10.4081/reumatismo.2011.91

  • 1,752 abstract views
  • 946 PDF

• PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study

  Chiara Cardelli^1|2, Chiara Tani¹, Luca Moroni³, Filippo Vesentini⁴, Francesca Bottazzi⁵, Micaela Fredi⁶, Ettore Silvagni⁷, Matteo Piga⁸, Flavia Riccio⁹, Fulvia Ceccarelli¹⁰, Ginevra De Marchi¹¹, Edoardo Biancalana¹², Gianluca Moroncini¹³, Rita Mulè¹⁴, Mariele Gatto¹⁵, Laura Coladonato¹⁶, Paola Conigliaro¹⁷, Maria Gerosa¹⁸, Andrea Picchianti Diamanti¹⁹, Benedetta Bianchi²⁰, Federica Maiolini²⁰, Michela Gasparotto²⁰, Serena Guiducci²⁰, Maria Ilenia De Andres²⁰, Alberto Lo Gullo²⁰, Silvia Noviello²⁰, On Behalf Of The Reveal Investigators²⁰, Marta Mosca¹. | ¹Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; ²Department of Medical Biotechnologies, University of Siena, Siena; ³Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; ⁴Rheumatology Unit, Department of Medicine, University of Padua, Padova; ⁵Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; ⁶Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; ⁷Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; ⁸Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari;  ⁹Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; ¹⁰Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; ¹¹Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; ¹²Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; ¹³Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; ¹⁴Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; ¹⁵Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; ¹⁶Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; ¹⁷Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; ¹⁸Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; ¹⁹Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; ²⁰Italian REVEAL Study Group Italy, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2031

  • 407 abstract views

• PO:15:208 | Impact of disease control on organ damage accrual in patients with systemic lupus erythematosus with and extra-renal flares: a 12-month single-center longitudinal study

  Giorgia Capozzo¹, Marco Oliva¹, Giancarlo Cascarano¹, Chiara Cardelli¹, Dina Zucchi¹, Chiara Stagnaro², Viola Signorini², Elena Elefante², Chiara Tani¹, Marta Mosca¹. | ¹Università di Pisa, Dipartimento di Medicina Clinica e Sperimentale, Pisa, Italy; ²Azienda Ospedaliero Universitaria Pisana, U.O. Reumatologia, Pisa, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2037

  • 314 abstract views
• 

  Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement

  Sara Ferrigno, Immacolata Prevete, Valeria Orefice, Chiara Scirocco, Gian Domenico Sebastiani

  08-04-2026

  DOI https://doi.org/10.4081/reumatismo.2026.1956

  • 3,324 abstract views
  • 364 PDF

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  Pages 109-113

  DOI https://doi.org/10.4081/reumatismo.2005.109

  • 1,287 abstract views
  • 4,153 PDF
• 

  Clinical profile of patients with lupus psychosis in a Colombian cohort

  M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García

  13-09-2022

  DOI https://doi.org/10.4081/reumatismo.2022.1483

  • 1,937 abstract views
  • 1,017 PDF

• PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case

  Veronica Spedicato¹, Laura Coladonato¹, Marco Fornaro¹, Marlea Lavista¹, Daniele Sabella¹, Marco Capodiferro¹, Maria Morrone¹, Crescenzio Scioscia¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area Jonica^J, University of Bari, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2161

  • 327 abstract views
• 

  Epidemiology and demographics of cutaneous lupus erythematosus in Colombia between 2015 and 2019

  D.G. Fernández Ávila, M. Rivera Maldonado, L.P. Charry Anzola

  08-05-2023

  DOI https://doi.org/10.4081/reumatismo.2023.1568

  • 2,242 abstract views
  • 1,859 PDF
• 

  Quality of life measures in systemic lupus erythematosus: a systematic review

  M. Radin, G. El Hasbani, A. Barinotti, D. Roccatello, I. Uthman, A. Taher, S. Sciascia

  07-02-2022

  DOI https://doi.org/10.4081/reumatismo.2021.1447

  • 9,173 abstract views
  • 3,342 PDF

• PO:10:144 | Management of pure red cell aplasia as the onset of systemic lupus erythematosus: a case report

  Chrystel Carolin Navarrete Cadena¹, Marika Tardella¹ | ¹Università Politecnica delle Marche Jesi, Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2310

  • 258 abstract views

• PO:17:253 | Unveiling the gap: a multicenter study on factors driving patient-physician discrepancies in assessing disease activity in systemic lupus erythematosus

  Giorgia Ingrid Gozzoli¹, Micaela Fredi¹, Federica Bonaso¹, Silvia Ebe Lucia Della Pina¹, Claudia Barison¹, Irene Lorenzini⁴, Raffaele Pericotti⁴, Anna Mattiuzzo⁴, Marcelo Neto², Sofia Azevedo³, Cláudia Oliveira³, Cesare Tomasi⁴, Luís Sousa Inês², Franco Franceschini¹. | ¹Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; ²Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; ³Rheumatology  Department, ULS Aveiro, Aveiro, Portugal; ⁴Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2046

  • 329 abstract views

• PO:14:207 | Nailfold capillaroscopy in systemic lupus erythematosus: microvascular alterations and their clinical relevance

  Giulia Cassone¹, Filippo Santoro², Maria Grazia Malandra², Bruno Biasi², Elena Vanni², Caterina Vacchi¹, Alesandra Carobbio³, Dilia Giuggioli^1|2. | ¹Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; ²Università di Modena e Reggio Emilia, Modena, Italy; ³Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Univeristà di Modena e Reggio Emilia, Modena, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2036

  • 320 abstract views

• Drug-induced lupus erythematosus

  F. Atzeni, M.G. Marrazza, P. Sarzi-Puttini, M. Carrabba

  Pages 147-154

  DOI https://doi.org/10.4081/reumatismo.2003.147

  • 7,822 abstract views
  • 19,321 PDF

• PO:14:206 | Factors impacting subjective cognitive impairment in systemic lupus erythematosus patients: clearing away the lupus brain fog

  Elisabetta Chessa¹, Marta Paola Pireddu², Fabio Congiu², Giulia Rizzo², Cristina Serafini³, Elena Ragusa², Alberto Cauli^1|2, Matteo Piga^1|2. | ¹SC Reumatologia- AOU Cagliari, Cagliari, Italy; ²Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy; ³PO Sirai - Unità di Nefrologia e Dialisi, Carbonia (CA), Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2035

  • 394 abstract views

• PO:14:198 | Temporal Trends in LLDAS and DORIS Achievement in SLE: Impact of Evolving International Recommendations

  Laura Coladonato¹, Marco Fornaro¹, Angelica Napoletano¹, Daniele Catamerò¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹UOC Reumatologia, Policlinico di Bari, DiMePre-J Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2321

  • 155 abstract views

• PO:14:203 | Impact of anifrolumab on depressive symptoms in systemic lupus erythematosus: results from a single-centre prospective observational study

  Luca Moroni¹, Biancamaria Venerandi¹, Maria Cilona¹, Anna Vivona¹, Gabriele Gallina¹, Giovanni Benanti¹, Enrica Bozzolo¹, Giuseppe Ramirez¹, Marco Matucci-Cerinic¹, Lorenzo Dagna¹. | ¹U.O. di Immunologia, Reumatologia, Allergologia e Malattie Rare - IRCCS Ospedale San Raffaele, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2032

  • 298 abstract views
• 

  The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

  Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino

  23-07-2025

  DOI https://doi.org/10.4081/reumatismo.2025.1830

  • 2,833 abstract views
  • 566 PDF

• PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus

  Antonella Grimaldi¹, Giuseppe Alessandrini², Laura Quarta¹, Maria Rita Ricciardi¹, Daniela Costanza¹, Clara Minerba¹, Eugenio Quarta¹ | ¹UOC Reumatologia Verona; ²Specialista Dermatologo in Libera Professione, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2170

  • 355 abstract views

• Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review

  S. Scriffignano, F.M. Perrotta, M. Ricci, B. Carabellese, E. Lubrano

  24-09-2024

  DOI https://doi.org/10.4081/reumatismo.2024.1647

  • 1,413 abstract views
  • 581 PDF

• PO:18:271 | Managing concomitant sle and psoriasis: the role of anifrolumab in a clinical case

  Angela Carenza¹, Liliana Dinoia², Sergio De Gioia², Federica Gatti¹, Teresa Caferri¹, Lucia Cristiana Colaprico¹, Angelica Napoletano¹, Giuseppe Lopalco¹, Florenzo Iannone¹. | ¹Rheumatology Unit, University of Bari, Department of Precision and Regenerative Medicine, Jonian area ^DiMePRe-J, Bari, Italy; ²Azienda Sanitaria Locale di Taranto, presidio ospedaliero SS. Annunziata, Unità Operativa di Reumatologia, Taranto, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2047

  • 514 abstract views
• 

  Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren’s disease

  Said Taharboucht, Chaima Mehiris, Sonia Bellil, Zahira Chikh Salah, Lydia Bentaleb

  10-06-2026

  DOI https://doi.org/10.4081/reumatismo.2026.1930

  • 2,205 abstract views
  • 281 PDF

• Clinical profile of patients with lupus nephritis

  T.L. Skare, A.C. Schönrock

  Pages 316-317

  DOI https://doi.org/10.4081/reumatismo.2009.316

  • 1,182 abstract views
  • 840 PDF
• 

  Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa

  A.A. Akpabio, B.I. Otike-Odibi

  23-07-2020 Pages 115-119

  DOI https://doi.org/10.4081/reumatismo.2020.1274

  • 1,689 abstract views
  • 1,063 PDF

• PO:11:167 | Subtle symptoms masking a challenging diagnosis: a clinical case of intestinal vasculitis in systemic lupus erythematosus

  Ilaria Pace¹, Giulia Rizzo¹, Elisabetta Chessa², Davide Corradini¹, Roberta Origa¹, Valentina Ibba², Alberto Floris^1|2, Alberto Cauli^1|2, Matteo Piga^1|2 | ¹Sapienza Università di Roma; ²SC Reumatologia, AOU Cagliari, Cagliari, Italy 

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2153

  • 751 abstract views

• PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology

  Davide Rozza¹, Carlo Alberto Scirè^1|2, Paola Conigliaro³, Giacomo Emmi⁴, Laura Coladonato⁶, Salvatore Scarpato⁷, Luca Iaccarino⁸, Serena Guiducci⁹, Giulia Pazzola¹⁰, Francesca Romana Spinelli¹¹, Micol Frassi¹², Ilaria Cavazzana¹², Chiara Scirocco¹³, Valeria Orefice¹³, Immacolata Prevete¹³, Alessandra Bortoluzzi¹⁴, Marcello Govoni¹⁴, Elena Bartoloni¹⁵, Luca Moroni¹⁶, Giuseppe Alvise Ramirez¹⁶, Valentina Canti¹⁶, Giorgio Pettiti¹⁷, Maria Chiara Ditto¹⁸, Enrico Fusaro¹⁸, Marta Mosca¹⁹, Lorenzo Cavagna²⁰, Fabrizio Conti¹¹, Andrea Doria⁸, Gian Domenico Sebastiani¹³, Sperimentatori Gruppo Lire⁵ | ¹Centro Studi della Società Italiana di Reumatologia, Milano; ²Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; ³Università di Roma Tor Vergata; ⁴Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; ⁵https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; ⁶Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; ⁷Azienda Sanitaria Locale ^ASL Salerno; ⁸Università degli Studi di Padova; ⁹SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; ¹⁰Arcispedale Santa Maria Nuova Reggio Emilia; ¹¹Università degli Studi di Roma La Sapienza; ¹²Spedali Civili di Brescia; ¹³Azienda Ospedaliera San Camillo Forlanini, Roma; ¹⁴Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; ¹⁵SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; ¹⁶IRCCS Ospedale San Raffaele, Milano; ¹⁷Azienda Ospedaliera S. Croce e Carle, Cuneo; ¹⁸AOU Citta' della Salute e della Scienza di Torino; ¹⁹AOU Santa Chiara, Pisa; ²⁰Università di Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2158

  • 337 abstract views